NEXIEN BIOPHARMA, INC. Retained Earnings
NEXIEN BIOPHARMA, INC. had Retained Earnings of -$11.64 million as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-05-14
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$11.64M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$11.61M.
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$11.57M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$11.53M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2025-03-31 | -$11.64M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$11.61M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | -$11.57M 10-Q · filed 2024-11-18 | |
| 2024-06-30 | -$11.53M 10-Q · filed 2025-05-14 | |
| 2024-03-31 | -$11.45M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$11.39M 10-Q · filed 2024-02-20 | |
| 2023-09-30 | -$11.37M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$11.30M 10-K · filed 2024-10-22 | |
| 2023-03-31 | -$11.20M 10-Q · filed 2023-05-17 | |
| 2022-12-31 | -$11.12M 10-Q · filed 2023-02-08 | |
| 2022-09-30 | -$11.03M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$10.93M 10-K · filed 2023-09-28 | |
| 2022-03-31 | -$10.84M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$10.65M 10-Q · filed 2022-02-08 | |
| 2021-09-30 | -$10.43M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | -$10.31M 10-K · filed 2022-09-28 | |
| 2021-03-31 | -$10.13M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | -$10.34M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | -$9.51M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | -$8.45M 10-K · filed 2021-10-12 | |
| 2020-03-31 | -$7.77M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | -$7.21M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | -$6.52M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$5.78M 10-K · filed 2020-09-28 | |
| 2019-03-31 | -$4.72M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | -$4.23M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | -$2.27M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | -$1.47M 10-K · filed 2019-09-30 | |
| 2018-03-31 | -$1.21M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$945.77K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | -$540.43K 10-Q · filed 2017-11-03 | |
| 2017-06-30 | -$191.43K 10-K · filed 2018-09-28 | -$93.90K 10-K · filed 2017-07-31 |
| 2017-03-31 | -$89.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | -$83.72K 10-Q · filed 2017-02-06 | |
| 2016-09-30 | -$78.93K 10-Q · filed 2016-10-19 | |
| 2016-06-30 | -$72.23K 10-K · filed 2017-07-31 | |
| 2016-03-31 | -$67.44K 10-Q · filed 2016-04-13 | |
| 2015-12-31 | -$62.20K 10-Q · filed 2016-02-04 | |
| 2015-09-30 | -$57.72K 10-Q · filed 2015-10-14 | |
| 2015-06-30 | -$51.24K 10-K · filed 2016-09-28 | |
| 2015-03-31 | -$47.01K 10-Q · filed 2015-05-06 | |
| 2014-12-31 | -$43.14K 10-Q · filed 2015-02-13 | |
| 2014-06-30 | -$2.80K 10-K · filed 2015-09-15 |